 Jonathan Kurche
Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 12 | 2026 | 692 | 2.290 |
Why?
| | Mucin-5B | 8 | 2026 | 234 | 2.130 |
Why?
| | Interleukin-6 | 2 | 2022 | 776 | 0.680 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 71 | 0.570 |
Why?
| | Cysts | 1 | 2019 | 112 | 0.560 |
Why?
| | Bleomycin | 4 | 2023 | 255 | 0.490 |
Why?
| | Phenotype | 1 | 2024 | 3155 | 0.470 |
Why?
| | OX40 Ligand | 2 | 2011 | 10 | 0.410 |
Why?
| | Interferon Type I | 2 | 2011 | 147 | 0.400 |
Why?
| | Dendritic Cells | 3 | 2011 | 499 | 0.400 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2011 | 35 | 0.370 |
Why?
| | Bronchioles | 2 | 2026 | 29 | 0.360 |
Why?
| | Membrane Glycoproteins | 2 | 2011 | 499 | 0.360 |
Why?
| | Tumor Necrosis Factors | 1 | 2011 | 10 | 0.360 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1407 | 0.350 |
Why?
| | Promoter Regions, Genetic | 3 | 2026 | 1246 | 0.340 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 919 | 0.330 |
Why?
| | CD27 Ligand | 1 | 2010 | 9 | 0.320 |
Why?
| | T-Lymphocyte Subsets | 1 | 2011 | 418 | 0.300 |
Why?
| | Pulmonary Fibrosis | 2 | 2022 | 395 | 0.270 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2026 | 118 | 0.270 |
Why?
| | Lymphocyte Activation | 1 | 2011 | 1132 | 0.260 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2011 | 919 | 0.260 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2011 | 1140 | 0.250 |
Why?
| | Respiratory Mucosa | 4 | 2025 | 322 | 0.250 |
Why?
| | Lung Diseases, Interstitial | 2 | 2021 | 664 | 0.210 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2023 | 32 | 0.200 |
Why?
| | Mice | 9 | 2023 | 18329 | 0.200 |
Why?
| | Lung | 6 | 2026 | 4106 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.170 |
Why?
| | Mice, Transgenic | 2 | 2019 | 2188 | 0.160 |
Why?
| | Animals | 12 | 2025 | 38030 | 0.160 |
Why?
| | Cell Communication | 1 | 2022 | 328 | 0.160 |
Why?
| | Ligands | 1 | 2022 | 665 | 0.160 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2021 | 98 | 0.160 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 93 | 0.150 |
Why?
| | Keratin-15 | 1 | 2019 | 16 | 0.150 |
Why?
| | Colloids | 1 | 2019 | 59 | 0.150 |
Why?
| | Aged | 7 | 2026 | 26153 | 0.150 |
Why?
| | Pulmonary Alveoli | 2 | 2025 | 385 | 0.140 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 81 | 0.140 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 159 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 782 | 0.130 |
Why?
| | Mice, Knockout | 4 | 2011 | 3124 | 0.120 |
Why?
| | Mucociliary Clearance | 1 | 2016 | 44 | 0.120 |
Why?
| | RNA | 1 | 2022 | 910 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2378 | 0.120 |
Why?
| | Cholestyramine Resin | 1 | 2015 | 6 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 56 | 0.110 |
Why?
| | Hemothorax | 1 | 2015 | 16 | 0.110 |
Why?
| | Pericardial Effusion | 1 | 2015 | 22 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2028 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2597 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2011 | 4148 | 0.110 |
Why?
| | Humans | 16 | 2026 | 145475 | 0.110 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 98 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1767 | 0.100 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 248 | 0.100 |
Why?
| | Shock, Septic | 1 | 2015 | 227 | 0.100 |
Why?
| | Mice, Inbred C57BL | 4 | 2011 | 5983 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.090 |
Why?
| | Antirheumatic Agents | 1 | 2015 | 307 | 0.090 |
Why?
| | Radiation Chimera | 1 | 2011 | 28 | 0.090 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 84 | 0.090 |
Why?
| | Cross-Priming | 1 | 2011 | 16 | 0.090 |
Why?
| | Toll-Like Receptor 7 | 1 | 2011 | 43 | 0.080 |
Why?
| | Female | 8 | 2026 | 78845 | 0.080 |
Why?
| | Male | 8 | 2026 | 72843 | 0.080 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2010 | 28 | 0.080 |
Why?
| | Vaccinia virus | 1 | 2010 | 35 | 0.080 |
Why?
| | Antigen Presentation | 1 | 2011 | 207 | 0.080 |
Why?
| | Middle Aged | 4 | 2026 | 36215 | 0.080 |
Why?
| | CD40 Antigens | 1 | 2010 | 90 | 0.080 |
Why?
| | Listeria monocytogenes | 1 | 2010 | 102 | 0.070 |
Why?
| | Toll-Like Receptors | 1 | 2010 | 193 | 0.070 |
Why?
| | Signal Transduction | 3 | 2011 | 5216 | 0.070 |
Why?
| | Immunization | 1 | 2010 | 375 | 0.070 |
Why?
| | B7-2 Antigen | 1 | 2007 | 27 | 0.070 |
Why?
| | Vaccines | 1 | 2012 | 388 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1210 | 0.060 |
Why?
| | B7-1 Antigen | 1 | 2007 | 55 | 0.060 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 82 | 0.060 |
Why?
| | X-Box Binding Protein 1 | 1 | 2026 | 16 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2010 | 1162 | 0.060 |
Why?
| | Uteroglobin | 1 | 2026 | 30 | 0.060 |
Why?
| | Stroke | 1 | 2015 | 1270 | 0.060 |
Why?
| | Laser Capture Microdissection | 1 | 2025 | 29 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2007 | 385 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1996 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2007 | 409 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2B | 1 | 2023 | 6 | 0.050 |
Why?
| | Global Burden of Disease | 1 | 2021 | 24 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 310 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2021 | 123 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 559 | 0.040 |
Why?
| | A549 Cells | 1 | 2021 | 75 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 35 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.040 |
Why?
| | Heart Transplantation | 1 | 2007 | 680 | 0.040 |
Why?
| | Proteome | 1 | 2025 | 514 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 191 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 1025 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.040 |
Why?
| | Models, Genetic | 1 | 2021 | 524 | 0.030 |
Why?
| | Proteomics | 1 | 2025 | 1188 | 0.030 |
Why?
| | Global Health | 1 | 2021 | 403 | 0.030 |
Why?
| | Lung Injury | 1 | 2021 | 244 | 0.030 |
Why?
| | Binding Sites | 1 | 2021 | 1310 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2021 | 350 | 0.030 |
Why?
| | Transcriptome | 1 | 2023 | 1038 | 0.030 |
Why?
| | Chromatin | 1 | 2021 | 553 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 679 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2022 | 1131 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1476 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2823 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 100 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2923 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2158 | 0.020 |
Why?
| | Vaccines, Subunit | 1 | 2012 | 53 | 0.020 |
Why?
| | Receptors, Interleukin-12 | 1 | 2011 | 6 | 0.020 |
Why?
| | Immunity, Humoral | 1 | 2012 | 118 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2012 | 274 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 119 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8333 | 0.020 |
Why?
| | Transplantation, Heterotopic | 1 | 2007 | 16 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10885 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 207 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2007 | 418 | 0.010 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 191 | 0.010 |
Why?
| | Spleen | 1 | 2007 | 508 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2769 | 0.010 |
Why?
| | Graft Survival | 1 | 2007 | 518 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1261 | 0.010 |
Why?
| | Graft Rejection | 1 | 2007 | 521 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 523 | 0.010 |
Why?
| | Myocardium | 1 | 2007 | 934 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2015 | 11772 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40777 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7123 | 0.010 |
Why?
|
|
Kurche's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|